Triacylglycerol and coronary heart disease

Proceedings of the Nutrition Society

Volumn 56, Issue 2, 1997, Pages 667-670

  Austin, Melissa A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

BLOOD; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; REVIEW; RISK FACTOR;

CORONARY DISEASE; FEMALE; HUMANS; MALE; RISK FACTORS; TRIGLYCERIDES;

EID: 0031179464     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS19970066     Document Type: Article

References (24)

1. Assmann, G., Schulte, H. & von Eckardstein, A. (1996). Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. American Journal of Cardiology 77, 1179-1184.
2. Austin, M. A. (1991). Triglycerides and coronary heart disease. Arteriosclerosis & Thrombosis 11, 2-14.
3. Austin, M. A., Breslow, J. L., Hennekens, C. H., Buring, J. E., Willett, W. S. & Krauss, R. M. (1988). Low-density lipoprotein subclass patterns and risk of myocardial infarction. Journal of the American Medical Association 260, 1917-1921.
4. Austin, M. A., Hokanson, J. E. & Brunzell, J. D. (1994). Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Current Opinion in Lipidology 5, 395-403.
5. Austin, M. A., King, M.-C., Vranizan, K. M. & Krauss, R. M. (1990). Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 82, 495-506.
6. Austin, M. A., Mykkänen, L., Kuusisto, J., Edwards, K. L., Nelson, C., Haffner, S. M., Pyörälä, K. & Laakso, M. (1995). Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes. Circulation 92, 1770-1778.
7. Burchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, L-J., Chiu, D., Rodriguez, B. L., Curb, J. D. & Sharp, D. S. (1995) . Combined effects of HDL cholesterol, triglyceride and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 92, 1430-1436.
8. Defronzo, R. A. & Ferrannini, E. (1991). Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14, 173-194.
9. Edwards, K. L., Austin, M. A., Newman, B., Mayer, E., Krauss, R. M. & Selby, J. V. (1994). Multivariate analysis of the insulin resistance syndrome in women. Arteriosclerosis & Thrombosis 14, 1940-1945.
10. Edwards, K. L., Burchfiel, C. M., Sharp, D. S., Curb, J. D., Rodriguez, B. L., LaCroix, A. Z., Vitiello, M. V. & Austin, M. A. (1996). Multivariate factors of the insulin resistance syndrome (IRS) in elderly Japanese American men. Diabetes 45, Suppl. 2, 280A.
11. Ferrannini, E., Haffner, S. M., Mitchell, B. D. & Stern, M. P. (1991). Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416-422.
12. Gardner, C. D., Fortmann, S. P. & Krauss, R. M. (1996). Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Journal of the American Medical Association 276, 875-881.
13. Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J. & Shepherd, J. (1994). Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106, 241-253.
14. Hokanson, J. E. & Austin, M. A. (1996). Plasma triglyceride level is an independent risk factor for cardiovascular disease: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 3, 213-219.
15. Levine, G. N., Keaney, J. F. & Vita, J. A. (1995). Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. New England Journal of Medicine 332, 512-521.
16. Mahaney, M. C., Blangero, J., Comuzzie, A. G., Vandeberg, J. L., Stern, M. P. & MacCluer, J. W. (1995). Plasma HDL cholesterol, triglyceride and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Heart Study. Circulation 92, 3240-3248.
17. NIH Consensus Development Panel on Triglyceride, High Density Lipoprotein and Coronary Heart Disease (1993). Triglyceride, high density lipoprotein and coronary heart disease. Journal of the American Medical Association 269, 505-510.
18. Reaven, G. M. (1988). Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
19. Reaven, G. M., Chen, I. Y.-D., Jeppesen, J., Maheux, P. & Krauss, R. M. (1993). Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. Journal of Clinical Investigation 92, 141-146.
20. Scandinavian Simvastatin Survival Study Group (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389.
21. Selby, J. V., Austin, M. A., Newman, B., Zhang, D., Quesenberry, C. P., Mayer, E. J. & Krauss, R. M. (1993). LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88, 381-387.
22. Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., MacFarlane, P. W., McKillop, J. H. & Packard, C. J. for the West of Scotland Coronary Prevention Study Group (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine 333, 1301-1307.
23. Sprecher, D. L., Hein, M. J. & Laskarzewski, P. M. (1994). Conjoint high triglycerides and low HDL cholesterol across generations. Analysis of proband hypertriglyceridemia and lipid/lipoprotein disorders in first-degree family members. Circulation 90, 1177-1184.
24. Stampfer, M. J., Krauss, R. M., Blance, P. J., Holl, L.G., Sacks, F. M. & Hennekens, C. H. (1996). A prospective study of triglyceride level, low-density lipoprotein particle diameter and risk of myocardial infarction. Journal of the American Medical Association 276, 882-915.